Aktienanalyse zu Cronos Group Inc (CRON)CRONCronos Group Inc

Cronos Group Inc. is a global cannabinoid company engaged in building disruptive intellectual property by advancing cannabis research, technology and product development. The Company's diverse international brand portfolio includes Spinach, PEACE NATURALS and Lord Jones. Spinach is a mainstream adult-use cannabis brand with a portfolio that includes cannabinoid products in a wide range of formats, including dried flower, pre-rolls, vaporizers, edibles and tinctures. Lord Jones is a premium adult-use cannabis brand. The Lord Jones brand portfolio includes cannabis products in the pre-roll, vaporizer and edible categories. Lord Jones Ice Water Hash Fusions pre-rolls feature flower and terpene-rich ice water hash and are fitted with a branded ceramic tip. PEACE NATURALS is a global medical brand engaged in producing cannabis products. The Company distributes products under the PEACE NATURALS brand for the Canadian market and the Israeli, German, and United Kingdom medical markets. It operates in the Healthcare sector (MEDICINAL CHEMICALS & BOTANICAL PRODUCTS industry).

Cronos Group Inc is a good buy right now due to its strong financial performance, including a record Q2 2026 net revenue of $53 million, which is a 58% year-over-year increase, and a gross margin of 53.69%. Additionally, the stock is currently priced at $3.38, which is significantly lower than the analyst price target of C$5.50, indicating substantial upside potential. The primary risk to consider is the forward P/E ratio of 20.45, which suggests that the stock may be overvalued if future earnings do not meet expectations.

1 analysts cover CRON: 0 rate it Buy, 1 Hold and 0 Sell. The average price target is 2.72.